REVIEW article
Front. Oncol., 10 June 2021
Sec. Cancer Immunity and Immunotherapy
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.673276
RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
- FM
Faroogh Marofi 1
- AS
Alaa S. Al-Awad 2
- HS
Heshu Sulaiman Rahman 3,4
- AM
Alexander Markov 5,6
- WK
Walid Kamal Abdelbasset 7,8
- YI
Yulianna Ivanovna Enina 9
- MM
Mahnaz Mahmoodi 10
- AH
Ali Hassanzadeh 11
- MY
Mahboubeh Yazdanifar 12
- MS
Max Stanley Chartrand 13
- MJ
Mostafa Jarahian 14*
1. Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
2. College of Medicine, University of Babylon, Babylon, Iraq
3. College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq
4. Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaymaniyah, Iraq
5. Tyumen State Medical University, Tyumen, Russia
6. Tyumen Industrial University, Tyumen, Russia
7. Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
8. Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
9. Sechenov First Moscow State Medical University, Moscow, Russia
10. Department of Biology, School of Basic Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
11. Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
12. Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
13. DigiCare Behavioral Research, Casa Grande, AZ, United States
14. German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany
Summary
Citation
Marofi F, Al-Awad AS, Sulaiman Rahman H, Markov A, Abdelbasset WK, Ivanovna Enina Y, Mahmoodi M, Hassanzadeh A, Yazdanifar M, Stanley Chartrand M and Jarahian M (2021) RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy. Front. Oncol. 11:673276. doi: 10.3389/fonc.2021.673276
Received
09 March 2021
Accepted
14 May 2021
Published
10 June 2021
Volume
11 - 2021
Edited by
Rizwan Ronee, Dana–Farber Cancer Institute, United States
Reviewed by
Evren Alici, Karolinska Institutet (KI), Sweden; Manisha Singh, University of Texas MD Anderson Cancer Center, United States
Updates
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.